Stop Superbugs Act

The Stop Superbugs Act directs the National Institute of Allergy and Infectious Diseases to award a competitive grant for an Antibiotic Resistance Leadership Group. This group will establish a clinical research network focused on speeding up the recruitment of trial participants and conducting outreach in community settings. The bill also requires the network to integrate new diagnostic tools with pharmaceutical innovations during trials and develop patient-reported outcome measures. Funding is authorized to cover the costs associated with implementing these specific research initiatives.